Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
Brian G. Feagan, Bruce E Sands, Corey A. Siegel, Marla C. Dubinsky, Randy Longman, João Sabino, Olivier Laurent, Allison Luo, Jiandong Lu, Deanna D. Nguyen, Ernesto J. Muñoz‐Elías, Heather Llewellyn, Yong Wang, InSock Jang, Janine Bilsborough, Ronald R. Marchelletta, Fadi Towfic, Mark Yen, J. Anderson, Aaron DuVall, Jarosław Kierkuś, Marek Woynarowski, Houssam Al Kharrat, Stephan R. Targan, Dermot McGovern
Topics & Concepts
Crohn's diseaseMonoclonal antibodyMedicineDiseaseImmunologyMonoclonalClinical trialAntibodyInternal medicineInflammatory Bowel DiseaseRheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and Treatments